Klebsiella pneumoniae infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes

IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY
Guo Long, Peng Peng, Wei-Ting Peng, Jie Zhao, Qi-Quan Wan
{"title":"Klebsiella pneumoniae infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes","authors":"Guo Long, Peng Peng, Wei-Ting Peng, Jie Zhao, Qi-Quan Wan","doi":"10.4254/wjh.v16.i4.612","DOIUrl":null,"url":null,"abstract":"BACKGROUND\n Liver transplantation (LT) is the only curative treatment for end-stage liver disease. However, LT recipients are susceptible to infection, which is the leading cause of early mortality after LT. Klebsiella pneumoniae infections (KPIs) in the bloodstream are common in LT recipients. We hypothesized that KPIs and carbapenem-resistant Klebsiella pneumoniae (CRKP) infections may affect the outcomes of LT recipients.\n AIM\n To assess KPI incidence, timing, distribution, drug resistance, and risk factors following LT and its association with outcomes.\n METHODS\n This retrospective study included 406 patients undergoing LT at The Third Xiangya Hospital of Central South University, a tertiary hospital, from January 2015 to January 2023. We investigated the risk factors for KPIs and assessed the impact of KPIs and CRKP infections on the prognosis of LT recipients using logistic regression analysis.\n RESULTS\n KPI incidence was 7.9% (n = 32), with lung/thoracic cavity the most frequent site of infection; the median time from LT to KPI onset was 7.5 d. Of 44 Klebsiella pneumoniae isolates, 43 (97.7%) and 34 (77.3%) were susceptible to polymyxin B or ceftazidime/avibactam and tigecycline, respectively; > 70% were resistant to piperacillin/ tazobactam, ceftazidime, cefepime, aztreonam, meropenem, and levofloxacin. Female sex [odds ratio (OR) = 2.827, 95% confidence interval (CI): 1.256-6.364; P = 0.012], pre-LT diabetes (OR = 2.794, 95%CI: 1.070-7.294; P = 0.036), day 1 post-LT alanine aminotransferase (ALT) levels ≥ 1500 U/L (OR = 3.645, 95%CI: 1.671-7.950; P = 0.001), and post-LT urethral catheter duration over 4 d (OR = 2.266, 95%CI: 1.016-5.054; P = 0.046) were risk factors for KPI. CRKP infections, but not KPIs, were risk factors for 6-month all-cause mortality post-LT.\n CONCLUSION\n KPIs occur frequently and rapidly after LT. Risk factors include female sex, pre-LT diabetes, increased post-LT ALT levels, and urethral catheter duration. CRKP infections, and not KPIs, affect mortality.","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v16.i4.612","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Liver transplantation (LT) is the only curative treatment for end-stage liver disease. However, LT recipients are susceptible to infection, which is the leading cause of early mortality after LT. Klebsiella pneumoniae infections (KPIs) in the bloodstream are common in LT recipients. We hypothesized that KPIs and carbapenem-resistant Klebsiella pneumoniae (CRKP) infections may affect the outcomes of LT recipients. AIM To assess KPI incidence, timing, distribution, drug resistance, and risk factors following LT and its association with outcomes. METHODS This retrospective study included 406 patients undergoing LT at The Third Xiangya Hospital of Central South University, a tertiary hospital, from January 2015 to January 2023. We investigated the risk factors for KPIs and assessed the impact of KPIs and CRKP infections on the prognosis of LT recipients using logistic regression analysis. RESULTS KPI incidence was 7.9% (n = 32), with lung/thoracic cavity the most frequent site of infection; the median time from LT to KPI onset was 7.5 d. Of 44 Klebsiella pneumoniae isolates, 43 (97.7%) and 34 (77.3%) were susceptible to polymyxin B or ceftazidime/avibactam and tigecycline, respectively; > 70% were resistant to piperacillin/ tazobactam, ceftazidime, cefepime, aztreonam, meropenem, and levofloxacin. Female sex [odds ratio (OR) = 2.827, 95% confidence interval (CI): 1.256-6.364; P = 0.012], pre-LT diabetes (OR = 2.794, 95%CI: 1.070-7.294; P = 0.036), day 1 post-LT alanine aminotransferase (ALT) levels ≥ 1500 U/L (OR = 3.645, 95%CI: 1.671-7.950; P = 0.001), and post-LT urethral catheter duration over 4 d (OR = 2.266, 95%CI: 1.016-5.054; P = 0.046) were risk factors for KPI. CRKP infections, but not KPIs, were risk factors for 6-month all-cause mortality post-LT. CONCLUSION KPIs occur frequently and rapidly after LT. Risk factors include female sex, pre-LT diabetes, increased post-LT ALT levels, and urethral catheter duration. CRKP infections, and not KPIs, affect mortality.
肝移植后的肺炎克雷伯菌感染:耐药性和病原体分布、风险因素及对预后的影响
背景 肝移植(LT)是治疗终末期肝病的唯一方法。然而,肝移植受者很容易受到感染,而感染是导致肝移植后早期死亡的主要原因。LT受者血液中的肺炎克雷伯菌(KPI)感染很常见。我们假设 KPI 和耐碳青霉烯类肺炎克雷伯菌(CRKP)感染可能会影响 LT 受者的预后。目的 评估 KPI 的发生率、时间、分布、耐药性、LT 后的风险因素及其与预后的关系。方法 本回顾性研究纳入了 2015 年 1 月至 2023 年 1 月期间在三级甲等医院中南大学湘雅三医院接受 LT 治疗的 406 例患者。我们调查了KPI的风险因素,并使用逻辑回归分析评估了KPI和CRKP感染对LT受者预后的影响。结果 KPI发病率为7.9%(n = 32),肺/胸腔是最常见的感染部位;从LT到KPI发病的中位时间为7.5 d。在44株肺炎克雷伯菌分离物中,43株(97.7%)和34株(77.3%)分别对多粘菌素 B 或头孢唑肟/阿维菌素和替加环素敏感;70%以上对哌拉西林/他唑巴坦、头孢唑肟、头孢吡肟、阿曲南、美罗培南和左氧氟沙星耐药。女性性别[几率比(OR)= 2.827,95% 置信区间(CI):1.256-6.364;P = 0.012]、LT 前糖尿病(OR = 2.794,95%CI:1.070-7.294;P = 0.036)、LT 后第 1 天丙氨酸氨基转移酶(ALT)水平≥ 1500 U/L(OR = 3.645,95%CI:1.671-7.950;P = 0.001)和LT后尿道导管持续时间超过4 d(OR = 2.266,95%CI:1.016-5.054;P = 0.046)是KPI的危险因素。CRKP感染是导致LT术后6个月全因死亡率的风险因素,而不是KPI。结论 KPI在LT后发生频繁且迅速。风险因素包括女性、LT前糖尿病、LT后ALT水平升高和尿道导管持续时间。影响死亡率的是 CRKP 感染,而非 KPI。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Hepatology
World Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.10
自引率
4.20%
发文量
172
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信